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Background
PIPA is designed to determine the feasibility of a prospec-
tive, multi-centre cohort study to assess the clinical and
cost-effectiveness of cardiac magnetic resonance imaging
(CMR) in patients who activate the primary percutaneous
coronary intervention (PPCI) pathway. A key PIPA objec-
tive is to define a primary composite outcome that repre-
sents a clinically important change in management (proxy
outcome for reduction in the future risk of a major
adverse cardiovascular event (MACE)) as a result of an eli-
gible patient having had CMR. A formal consensus
method based on the modified nominal group technique
[1] is being used to define this outcome.
Methods
Formal consensus is being developed in three phases: (1)
Systematic review to identify relevant literature; (2) For-
mulation of statements about how CMR changes patient
management; (3) Consensus process, in which an interdis-
ciplinary panel of stakeholders will complete an online
survey (rating statements for importance on a 9-point
Likert scale), attend a face-to-face consensus meeting to
discuss variation in anonymised survey responses, then
re-rate the survey statements.
Results
Sixteen statements will be rated by twelve panellists
(interventional cardiologists, CMR experts, cardiac net-
work directors, and GPs). Final survey results will be pre-
sented as medians, interquartile ranges (IQR), counts and
percentages. Statements with median scores of 7–9 and
IQR of <3 will be considered to be in consensus and used
to define the primary outcome.
Conclusions
The primary composite outcome will be used to evaluate
the effectiveness and cost-effectiveness of CMR to change
clinical management in ways expected to prevent future
MACE in this population.
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